
Isaac Shomer
Examiner (ID: 12146, Phone: (571)270-7671 , Office: P/1612 )
| Most Active Art Unit | 1612 |
| Art Unit(s) | 1612 |
| Total Applications | 1343 |
| Issued Applications | 756 |
| Pending Applications | 157 |
| Abandoned Applications | 491 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 17718949
[patent_doc_number] => 20220211668
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-07-07
[patent_title] => RAPID DISPERSE DOSAGE FORM
[patent_app_type] => utility
[patent_app_number] => 17/703214
[patent_app_country] => US
[patent_app_date] => 2022-03-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 16412
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 89
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17703214
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/703214 | RAPID DISPERSE DOSAGE FORM | Mar 23, 2022 | Pending |
Array
(
[id] => 17718903
[patent_doc_number] => 20220211622
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-07-07
[patent_title] => SYNTHETIC NANOSTRUCTURES INCLUDING NUCLEIC ACIDS AND/OR OTHER ENTITIES
[patent_app_type] => utility
[patent_app_number] => 17/703824
[patent_app_country] => US
[patent_app_date] => 2022-03-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 29098
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -30
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17703824
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/703824 | SYNTHETIC NANOSTRUCTURES INCLUDING NUCLEIC ACIDS AND/OR OTHER ENTITIES | Mar 23, 2022 | Abandoned |
Array
(
[id] => 17881037
[patent_doc_number] => 20220296514
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-09-22
[patent_title] => Composition and Method of Preparation for Lipid Formulations Comprising Charged Lipids
[patent_app_type] => utility
[patent_app_number] => 17/697939
[patent_app_country] => US
[patent_app_date] => 2022-03-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 8483
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -36
[patent_words_short_claim] => 68
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17697939
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/697939 | Composition and Method of Preparation for Lipid Formulations Comprising Charged Lipids | Mar 17, 2022 | Pending |
Array
(
[id] => 17835662
[patent_doc_number] => 20220272967
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-09-01
[patent_title] => COMPOSITIONS FOR CONTROLLED RELEASE OF ACTIVE INGREDIENTS AND METHODS OF MAKING SAME
[patent_app_type] => utility
[patent_app_number] => 17/695999
[patent_app_country] => US
[patent_app_date] => 2022-03-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 30567
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -30
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17695999
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/695999 | COMPOSITIONS FOR CONTROLLED RELEASE OF ACTIVE INGREDIENTS AND METHODS OF MAKING SAME | Mar 15, 2022 | Abandoned |
Array
(
[id] => 18286845
[patent_doc_number] => 20230102317
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-03-30
[patent_title] => POLYMER MEDICAMENT FOR TREATING HYPERKALEMIA AND PREPARATION METHOD THEREOF
[patent_app_type] => utility
[patent_app_number] => 17/696225
[patent_app_country] => US
[patent_app_date] => 2022-03-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 7414
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 36
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17696225
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/696225 | POLYMER MEDICAMENT FOR TREATING HYPERKALEMIA AND PREPARATION METHOD THEREOF | Mar 15, 2022 | Abandoned |
Array
(
[id] => 19156190
[patent_doc_number] => 20240148897
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-05-09
[patent_title] => COMPOSITION FOR IN VIVO DELIVERY OF RNA AND PREPERATION METHOD THEREFOR
[patent_app_type] => utility
[patent_app_number] => 18/279689
[patent_app_country] => US
[patent_app_date] => 2022-03-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 9108
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 10
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18279689
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/279689 | COMPOSITION FOR IN VIVO DELIVERY OF RNA AND PREPERATION METHOD THEREFOR | Mar 6, 2022 | Pending |
Array
(
[id] => 18777897
[patent_doc_number] => 11819573
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2023-11-21
[patent_title] => Treatment of hip pain with sustained-release liposomal anesthetic compositions
[patent_app_type] => utility
[patent_app_number] => 17/684805
[patent_app_country] => US
[patent_app_date] => 2022-03-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 22336
[patent_no_of_claims] => 27
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 137
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17684805
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/684805 | Treatment of hip pain with sustained-release liposomal anesthetic compositions | Mar 1, 2022 | Issued |
Array
(
[id] => 19216148
[patent_doc_number] => 20240180852
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-06-06
[patent_title] => TREATMENT FOR MALIGNANT PLEURAL EFFUSION IN HUMANS
[patent_app_type] => utility
[patent_app_number] => 18/263649
[patent_app_country] => US
[patent_app_date] => 2022-03-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 9760
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18263649
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/263649 | TREATMENT FOR MALIGNANT PLEURAL EFFUSION IN HUMANS | Mar 1, 2022 | Pending |
Array
(
[id] => 19111116
[patent_doc_number] => 20240122866
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-04-18
[patent_title] => CATIONIC POLYMER-FORMULATED NANOPARTICLES AND METHODS OF USE
[patent_app_type] => utility
[patent_app_number] => 18/547669
[patent_app_country] => US
[patent_app_date] => 2022-02-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 10582
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18547669
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/547669 | CATIONIC POLYMER-FORMULATED NANOPARTICLES AND METHODS OF USE | Feb 22, 2022 | Pending |
Array
(
[id] => 17625616
[patent_doc_number] => 20220160631
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-05-26
[patent_title] => ANTIFUNGAL NANOPARTICLES FOR TARGETED TREATMENT OF FUNGAL INFECTIONS
[patent_app_type] => utility
[patent_app_number] => 17/589554
[patent_app_country] => US
[patent_app_date] => 2022-01-31
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6034
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 10
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17589554
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/589554 | ANTIFUNGAL NANOPARTICLES FOR TARGETED TREATMENT OF FUNGAL INFECTIONS | Jan 30, 2022 | Abandoned |
Array
(
[id] => 19096275
[patent_doc_number] => 20240115502
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-04-11
[patent_title] => LIPOSOMES AND ITS USE FOR ENZYME DELIVERY
[patent_app_type] => utility
[patent_app_number] => 18/274631
[patent_app_country] => US
[patent_app_date] => 2022-01-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 22568
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -14
[patent_words_short_claim] => 139
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18274631
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/274631 | LIPOSOMES AND ITS USE FOR ENZYME DELIVERY | Jan 25, 2022 | Pending |
Array
(
[id] => 18108131
[patent_doc_number] => 20230001011
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-01-05
[patent_title] => NANOCOMPLEXES OF POLYANION-MODIFIED PROTEINS
[patent_app_type] => utility
[patent_app_number] => 17/581482
[patent_app_country] => US
[patent_app_date] => 2022-01-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5131
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -16
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17581482
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/581482 | NANOCOMPLEXES OF POLYANION-MODIFIED PROTEINS | Jan 20, 2022 | Abandoned |
Array
(
[id] => 17593609
[patent_doc_number] => 20220143182
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-05-12
[patent_title] => ACOUSTIC DRIVEN DRUG DELIVERY SYSTEMS
[patent_app_type] => utility
[patent_app_number] => 17/579832
[patent_app_country] => US
[patent_app_date] => 2022-01-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 38021
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 31
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17579832
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/579832 | Acoustic driven drug delivery systems | Jan 19, 2022 | Issued |
Array
(
[id] => 19297442
[patent_doc_number] => 20240226007
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-07-11
[patent_title] => NICOTINAMIDE ADENINE DINUCLEOTIDE (NAD) COMPOSITIONS, METHODS OF MANUFACTURING THEREOF, AND METHODS OF USE THEREOF
[patent_app_type] => utility
[patent_app_number] => 18/289200
[patent_app_country] => US
[patent_app_date] => 2022-01-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 23020
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => 0
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18289200
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/289200 | Nicotinamide adenine dinucleotide (NAD) compositions, methods of manufacturing thereof, and methods of use thereof | Jan 18, 2022 | Issued |
Array
(
[id] => 17759850
[patent_doc_number] => 20220233462
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-07-28
[patent_title] => BIODEGRADABLE MULTILAYER NANOCAPSULES FOR THE DELIVERY OF BIOLOGICALLY ACTIVE AGENTS IN TARGET CELLS
[patent_app_type] => utility
[patent_app_number] => 17/574933
[patent_app_country] => US
[patent_app_date] => 2022-01-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 9161
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -15
[patent_words_short_claim] => 108
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17574933
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/574933 | Biodegradable multilayer nanocapsules for the delivery of biologically active agents in target cells | Jan 12, 2022 | Issued |
Array
(
[id] => 17774868
[patent_doc_number] => 20220241217
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-08-04
[patent_title] => COMPOSITIONS FOR THE DELIVERY OF THERAPEUTIC AGENTS AND METHODS OF USE AND MAKING THEREOF
[patent_app_type] => utility
[patent_app_number] => 17/569967
[patent_app_country] => US
[patent_app_date] => 2022-01-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 35715
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17569967
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/569967 | COMPOSITIONS FOR THE DELIVERY OF THERAPEUTIC AGENTS AND METHODS OF USE AND MAKING THEREOF | Jan 5, 2022 | Abandoned |
Array
(
[id] => 19002020
[patent_doc_number] => 20240066091
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-02-29
[patent_title] => USE OF PLANT-DERIVED EXOSOMES FOR INDUCING DIFFERENTIATION OF STEM CELL SOURCES INTO CARTILAGE AND BONE CELLS
[patent_app_type] => utility
[patent_app_number] => 18/270844
[patent_app_country] => US
[patent_app_date] => 2021-12-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 2746
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -13
[patent_words_short_claim] => 108
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18270844
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/270844 | USE OF PLANT-DERIVED EXOSOMES FOR INDUCING DIFFERENTIATION OF STEM CELL SOURCES INTO CARTILAGE AND BONE CELLS | Dec 26, 2021 | Pending |
Array
(
[id] => 19018991
[patent_doc_number] => 20240075162
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-03-07
[patent_title] => REDUCED GRAPHENE OXIDE (rGO) BASED DRUG CARRIER SYSTEMS
[patent_app_type] => utility
[patent_app_number] => 18/259346
[patent_app_country] => US
[patent_app_date] => 2021-12-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 3920
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -14
[patent_words_short_claim] => 24
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18259346
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/259346 | REDUCED GRAPHENE OXIDE (rGO) BASED DRUG CARRIER SYSTEMS | Dec 23, 2021 | Pending |
Array
(
[id] => 20192343
[patent_doc_number] => 20250269053
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2025-08-28
[patent_title] => LIPID NANOPARTICLES COMPRISING MANNOSE OR USES THEREOF
[patent_app_type] => utility
[patent_app_number] => 18/038979
[patent_app_country] => US
[patent_app_date] => 2021-12-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 13925
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -20
[patent_words_short_claim] => 39
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18038979
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/038979 | LIPID NANOPARTICLES COMPRISING MANNOSE OR USES THEREOF | Dec 22, 2021 | Pending |
Array
(
[id] => 18953461
[patent_doc_number] => 20240041788
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-02-08
[patent_title] => COMPOSITION COMPRISING A COMBINATION GROWTH FACTORS FOR PREVENTING RADIATION-INDUCED DAMAGE IN CANCER PATIENTS TREATED WITH RADIOTHERAPY
[patent_app_type] => utility
[patent_app_number] => 18/258689
[patent_app_country] => US
[patent_app_date] => 2021-12-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 15438
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -11
[patent_words_short_claim] => 20
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18258689
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/258689 | COMPOSITION COMPRISING A COMBINATION GROWTH FACTORS FOR PREVENTING RADIATION-INDUCED DAMAGE IN CANCER PATIENTS TREATED WITH RADIOTHERAPY | Dec 16, 2021 | Pending |